CD19 Chimeric Antigen Receptor (CAR) T- Cell therapy with Tisagenlecleucel in Children with B-Cell Acute Lymphoblastic Leukemia: Preliminary Findings from a Tertiary Care Center
Year: 2025
Type: article
Abstract: Introduction: (CAR) T-cell therapy is an evolving therapy in children with relapsed/refractory B-Cell acute lymphoblastic leukemia (ALL).
Source: OncoDaily Medical Journal
Authors: Nada Alshaikh, Rodaina Abujoub, Rimaz Mustafa, Shabaz Memon, Ahmed Mahdi Yousif, Sami AlThubaiti, Mohammed Essa
Institution: National Guard Health Affairs
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4409398560